US Delivery Delivery, Kanada Kasuwancin Gida, Bayar da Harshen Turai

Apatinib (811803-05-1)

Rating:
5.00 daga 5 bisa 1 abokin ciniki rating
SKU: 811803-05-1. category:

AASraw yana tare da kira da kuma samar da samfurin daga gram zuwa umurnin taro na Apatinib (CAS 811803-05-1), a karkashin tsarin CGMP da tsarin kula da kyawawan dabi'u.

Apatinib, wani ƙananan ƙwayar ƙarancin tyrosine kinase wanda ke haifar da karuwar mai karfin ciwon kwayar cutar ta 2, ya yarda da adenocarcinoma na ƙwayar cuta a Sin a cikin Oktoba 2014. Wannan shine rahoto na farko game da amfani da shi don ciwon daji wanda ba dama ba ne wanda yake cike da cutar kamar yadda ta saba da ita a yau.

AASRAW foda PDF Icon

Samfur Description

Bidiyo Apatinib


Abatinib ainihin Mawallafi

name: Apatinib
CAS: 811803-05-1
Kwayoyin Formula: C24H23N5O
Girman kwayoyin halitta: 397.47232
Shawarwar Melt: 111-114 ° C
Ajiye Temp: -20 ° C
Color: Raunin Yellow to Yellow Solid


Apatinib (811803-05-1) amfani da shi a yanayin zagaye na steroid

names

Apatinib (CAS 811803-05-1), wanda aka fi sani da YN968D1, Mesylate.

Amfani da Apatinib

Magunguna marasa lafiya sun gudanar da jinsin Apatinib kowace rana don 28 kwanakin. An dakatar da Apatinib a kwayoyin da ke ƙasa da 750 mg / rana, 3 na 3 kashi akan iyakancewa da aka ruwaito a 1000 mg / rana kuma an ƙaddamar da kashi mafi ƙanƙanci a matsayin 850 mg / rana.

Gargaɗi akan Apatinib

Dole ne ku san sakamako masu illa idan kun ɗauki Apatinib. Sakamakon haɓakar jini da ƙafar ƙafafun ƙarancin na karshe; Duk da haka, illa mai guba na apatinib ya kasance mai kulawa da damuwa.

Karin bayani

Rivoceranib (Apatinib, YN968D1) shine dan takarar kwayar magani na kwayoyin halitta wanda LSK BioPharma ke bunkasa a waje na Sin, don maganin ciwon daji da ciwon daji ko ciwon daji na ciwon sukari, ciwon daji na maganin ciwon daji, da kuma karamin ciwon hepatocellular. YN968D1 da farko sun hada da kuma ƙaddamar da su ta hanyar Advenchen Laboratories a Kudancin California. A halin yanzu an sayar da Apatinib a kasar Sin don ciwon daji na ciwon daji ta hannun mai amfani da lasisin kasar Sin, mai suna Jiangsu Hengrui MedicineCo, karkashin kamfanin Aitan®. LSK BioPharma yana da hakkoki na duniya (ban da China) kuma ya hade don ci gaba da sayar da rivoceranibin ta Kudu ta Korea.

Rivoceranib wani zaɓi ne wanda zai iya hana mai kwakwalwa mai karfin mahaifa-2 (wanda aka sani da VEGFR2) wanda ke jagorantar hanya ta farko don tumor-mediatedangiogenesis. An gwada shi a asibiti a kan marasa lafiya na 1,000 a dukan duniya kuma ya ba da tasiri ga yawancin cututtukan da suka hada da ciwon daji, ciwon daji, da ciwon maganin ciwon daji, kwayar cutar kanjamau, thyroidcancer, mesothelioma, da ciwon neuroendocrin. Har ila yau, ya nuna yiwuwar bunkasa sakamakon haɓaka tare da chemotherapeutics da immunotherapy, kazalika da magance farfadowa.


Yadda ake saya Apatinib daga AASraw

1.To tuntube mu ta hanyar imel ɗinmu tsarin bincike, ko skypewakilin sabis na abokin ciniki (CSR).
2.To samar mana da tambaya da adireshinka.
3.Our CSR zai ba ka zance, lokacin biya, lambar ƙididdiga, hanyoyin bayardawa da kuma kwanan wata zuwa ranar da aka zo (ETA).
4.Bayayyar da aka yi kuma za'a fitar da kayayyaki a cikin 12 hours (Domin a cikin 10kg).
5.Goods samu da bada comments.

BATSA DA TATTAUNAWA:

Ana Samun Wannan Abubuwan ne Don Amfani da Bincike Kawai. Sharuɗɗan Siyarwa suna Aiwatarwa. Ba don Amfani da Dan Adam bane, ko Likita, dabbobi, ko Amfani na Gida.


=

COA

HNMR

Recipes

Karin bayani & amsoshin samfurin